FDA approves sANDA for Glenmark Pharmaceuticals’ Monroe facility
Glenmark Pharmaceuticals announced that the U.S. Food & Drug Administration provided its first supplemental Abbreviated New Drug Application (sANDA) approval for the company’s manufacturing facility in Monroe, N.C.